2
Registered trials
0
Recruiting
2
Unique sponsors
3
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Antimetabolite
1 substance
Taxane
1 substance
Phase I (Other):
1
Phase I (First in Human):
1
Phase I (Other)
1 trial-
EndedHutchmed Ltd. CommercialIMP not specified
Phase I (First in Human)
1 trial-
EndedActuate Therapeutics Limited CommercialELRAGLUSIB; GEMCITABINE; PACLITAXEL ALBUMIN-BOUND
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Hutchmed Ltd. | Commercial | 1 | Phase I (Other) | 0 |
| Actuate Therapeutics Limited | Commercial | 1 | Phase I (First in Human) | 0 |
New trials by year
2021
2